U.S. pharma giant copyright scrapped two experimental weight loss drugs past yr—a when-daily pill, lotiglipron, resulting from elevated liver enzymes along with a twice-each day pill, danuglipron, on account of potent Negative effects—but CEO Albert Bourla has explained the company is decided to “Participate in and win” from the weight prob